FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498397012 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498397012 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3357851001000118 Tablette de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799361000241114 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799361000241114 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3357851001000118 Tablette de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet (unit of presentation) Is a Unit of presentation (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Etoricoxib 90 mg and thiocolchicoside 8 mg conventional release and prolonged-release oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Etoricoxib 90 mg and thiocolchicoside 8 mg conventional release and prolonged-release oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Etoricoxib 90 mg and thiocolchicoside 8 mg conventional release and prolonged-release oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely sodium valproate 133 milligram and valproic acid 58 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely sodium valproate 133 milligram and valproic acid 58 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely sodium valproate 133 milligram and valproic acid 58 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely sodium valproate 200 milligram and valproic acid 87 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely sodium valproate 200 milligram and valproic acid 87 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely sodium valproate 200 milligram and valproic acid 87 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Ritonavir 50 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Ritonavir 50 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Retinol (as retinol palmitate) 10000 unit oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Retinol (as retinol palmitate) 10000 unit oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 2 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glimepiride 2 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 2 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 4 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glimepiride 4 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 4 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Glimepiride 1 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Glimepiride 1 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Glimepiride 1 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Glimepiride 4 mg and rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Glimepiride 4 mg and rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Glimepiride 4 mg and rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 500 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 500 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 500 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 1 gram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 1 gram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Alogliptin (as alogliptin benzoate) 6.25 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Alogliptin (as alogliptin benzoate) 6.25 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Alogliptin (as alogliptin benzoate) 25 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Alogliptin (as alogliptin benzoate) 25 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 850 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 850 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 850 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 1 g oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 1 g oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 1 g oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 500 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 500 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 500 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely ropinirole (as ropinirole hydrochloride) 4 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ropinirole (as ropinirole hydrochloride) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely ropinirole (as ropinirole hydrochloride) 3 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ropinirole (as ropinirole hydrochloride) 3 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Ropinirole (as ropinirole hydrochloride) 500 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Ropinirole (as ropinirole hydrochloride) 500 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Quetiapine (as quetiapine fumarate) 50 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Quetiapine (as quetiapine fumarate) 50 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely quinagolide (as quinagolide hydrochloride) 25 microgram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely quinagolide (as quinagolide hydrochloride) 25 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Quinagolide (as quinagolide hydrochloride) 50 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Quinagolide (as quinagolide hydrochloride) 50 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrochlorothiazide 25 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 25 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrochlorothiazide 25 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Naratriptan (as naratriptan hydrochloride) 1 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Naratriptan (as naratriptan hydrochloride) 1 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely terazosin (as terazosin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely terazosin (as terazosin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Sertraline (as sertraline hydrochloride) 25 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Sertraline (as sertraline hydrochloride) 25 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Vardenafil (as vardenafil hydrochloride) 2.5 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Vardenafil (as vardenafil hydrochloride) 2.5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2

Start Previous Page 78 of 87 Next End

This concept is not in any reference sets

Back to Start